Reported Jul 27, 2022 · Ongoing
Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark…
Glenmark Pharmaceuticals Inc., USA
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Glenmark Pharmaceuticals Inc., USA · 750 Corporate Dr · Mahwah, NJ · 07430-2009
Is this the product you have?
- Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only
- Manufactured forGlenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60
- Lot codes and dates
Lot#: 17201639Exp 08/202217201759Exp 09/202217202067Exp 10/202217210696Exp 02/202317210092Exp 11/202217210145Exp 12/202217210732Exp 02/202317211062Exp 04/202317211441Exp 05/202317211670Exp 06/202317211810Exp 07/2023172118621721202017212068Exp 08/202317212438Exp 10/20231722017217220251Exp 12/2023
- Amount recalled
- 168936 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specification : Capsule breakage
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Glenmark Pharmaceuticals Inc., USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.